Date Filed | Type | Description |
07/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/13/2023 |
144
| Form 144 - Report of proposed sale of securities: |
07/12/2023 |
144
| Form 144 - Report of proposed sale of securities: |
04/19/2023 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
04/05/2023 |
4
| Burrell Terry-Ann (CFO) has filed a Form 4 on Beam Therapeutics Inc.
Txns:
| Sold 2,454 shares
@ $30.31, valued at
$74.4k
Sold 2,186 shares
@ $29.0931, valued at
$63.6k
|
|
03/31/2023 |
4
| Burrell Terry-Ann (CFO) has filed a Form 4 on Beam Therapeutics Inc.
Txns:
| Granted 20,000 shares
@ $0 Granted 20,000 options to buy
@ $43.45, valued at
$869k
|
|
01/30/2023 |
4
| Burrell Terry-Ann (CFO) has filed a Form 4 on Beam Therapeutics Inc.
Txns:
| Sold 1,102 shares
@ $45.1572, valued at
$49.8k
Sold 36,152 shares
@ $45.0804, valued at
$1.6M
Exercised 1,102 options to buy
@ $13.68, valued at
$15.1k
Exercised 36,152 options to buy
@ $13.68, valued at
$494.6k
|
|
01/25/2023 |
4
| Burrell Terry-Ann (CFO) has filed a Form 4 on Beam Therapeutics Inc.
Txns:
| Sold 5,426 shares
@ $45.0221, valued at
$244.3k
Sold 14,810 shares
@ $45.014, valued at
$666.7k
Exercised 5,426 options to buy
@ $13.68, valued at
$74.2k
Exercised 14,810 options to buy
@ $13.68, valued at
$202.6k
|
|
01/20/2023 |
4
| Burrell Terry-Ann (CFO) has filed a Form 4 on Beam Therapeutics Inc.
Txns:
| Sold 47,195 shares
@ $45.14, valued at
$2.1M
Exercised 39,886 options to buy
@ $13.68, valued at
$545.6k
|
|
01/05/2023 |
4
| Burrell Terry-Ann (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns:
| Granted 1,821 shares
@ $0 |
|
10/05/2022 |
4
| Burrell Terry-Ann (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns:
| Granted 1,265 shares
@ $0 |
|
07/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/05/2022 |
4
| Burrell Terry-Ann (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns:
| Granted 1,788 shares
@ $0 |
|
04/04/2022 |
4
| Burrell Terry-Ann (CFO) has filed a Form 4 on Beam Therapeutics Inc.
Txns:
| Granted 15,000 shares
@ $0 Sold 1,787 shares
@ $59.11, valued at
$105.6k
|
|
02/02/2022 |
4
| Burrell Terry-Ann (CFO) has filed a Form 4 on Beam Therapeutics Inc.
Txns:
| Granted 30,000 options to buy
@ $69.21, valued at
$2.1M
|
|
01/05/2022 |
4
| Burrell Terry-Ann (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns:
| Granted 763 shares
@ $0 |
|
10/05/2021 |
4
| Burrell Terry-Ann (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns:
| Granted 629 shares
@ $0 |
|
07/06/2021 |
4
| Burrell Terry-Ann (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns:
| Granted 382 shares
@ $0 |
|
07/02/2021 |
4
| Burrell Terry-Ann (CFO) has filed a Form 4 on Beam Therapeutics Inc.
Txns:
| Sold 15,000 shares
@ $117, valued at
$1.8M
Sold 15,000 shares
@ $127, valued at
$1.9M
Exercised 30,000 options to buy
@ $13.68, valued at
$410.4k
|
|
04/22/2021 |
4
| Burrell Terry-Ann (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns:
| Disposed of 126,561 shares
@ $0 Acquired 126,561 shares
@ $0 Converted 6,250 shares
@ $0 Converted 12,500 options to buy
@ $18, valued at
$225k
Converted 404,688 options to buy
@ $2.22, valued at
$898.4k
|
|
04/19/2021 |
4
| Burrell Terry-Ann (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns:
| Granted 6,250 shares
@ $0 Granted 12,500 options to buy
@ $18, valued at
$225k
|
|
04/15/2021 |
3
| Burrell Terry-Ann (Director) has filed a Form 3 on RECURSION PHARMACEUTICALS, INC. |
04/02/2021 |
4
| Burrell Terry-Ann (CFO) has filed a Form 4 on Beam Therapeutics Inc.
Txns:
| Granted 17,500 shares
@ $0 Granted 35,000 options to buy
@ $80.04, valued at
$2.8M
|
|
01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/21/2020 |
4
| Burrell Terry-Ann (CFO) has filed a Form 4 on Beam Therapeutics Inc.
Txns:
| Exercised 7,309 options to buy
@ $13.68, valued at
$100k
|
|
02/05/2020 |
3
| Burrell Terry-Ann (CFO) has filed a Form 3 on Beam Therapeutics Inc. |